Cases & Deals

Antigenics develops patent portfolio for cancer and infectious disease therapies

Client(s) Antigenics, Inc.

Jones Day represented Antigenics, Inc. in the development of its patent portfolio and prosecution strategy relating to immunotherapy for cancer and infectious disease, and cancer chemotherapeutics including Oncophage® vaccine technology. This work includes counseling and participation in reexaminations and European oppositions.